🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PLAY and executed a BUY strategy, securing a +29.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$MLTX

MoonLake Immunotherapeutics

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL